Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Black Diamond Therapeutics, Inc
< Previous
1
2
Next >
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
April 07, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
April 03, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 12, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024
March 05, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
February 28, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones
January 04, 2024
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM
December 13, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
November 07, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 06, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535
October 14, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 04, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces CEO Transition
September 18, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
GTHX
Black Diamond Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial Expansion Cohorts Evaluating BDTX-1535 in Patients with Intrinsic Driver and Acquired Resistance EGFR Mutation Positive Non-Small Cell Lung Cancer
September 11, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
September 05, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 11, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock
June 29, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Proposed Public Offering of Common Stock
June 28, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Initial Dose Escalation Data Demonstrating Anti-Tumor Activity of BDTX-1535 in Non-Small Cell Lung Cancer Patients Across Multiple EGFR Mutation Families
June 27, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Promotion of Melanie Morrison to Chief Development Officer
June 13, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference
June 02, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 09, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Present at the Stifel 2023 Targeted Oncology Days
April 18, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Presents Trial in Progress Poster for BDTX-1535 and Preclinical Data on BDTX-1535 and BDTX-4933 at the 2023 American Association of Cancer Research Annual Meeting
April 17, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
March 09, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Present at the Cowen 43rd Annual Health Care Conference
February 27, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Changes to Board of Directors
December 19, 2022
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company
December 12, 2022
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
November 09, 2022
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
Black Diamond Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 08, 2022
From
Black Diamond Therapeutics, Inc
Via
GlobeNewswire
Tickers
BDTX
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today